Antifibrinolytic Agent class drugs

5 results

  • aminocaproic acid

    (Aminocaproic acid)
    BPI LABS LLC
    Aminocaproic acid oral solution is indicated for enhancing hemostasis in cases of fibrinolysis-related bleeding, particularly in surgical complications, hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. It also addresses excessive urinary tract bleeding due to surgical or nonsurgical conditions. Emergency measures may be necessary.
    Medication Details
    Drug Interactions

  • tranexamic acid

    (Tranexamic Acid)
    Micro Labs Limited
    Tranexamic acid injection is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage and minimize the need for replacement therapy during and after tooth extraction.
    Medication Details
    Drug Interactions

  • tranexamic acid

    (Tranexamic Acid)
    Amneal Pharmaceuticals LLC
    Tranexamic acid injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.
    Medication Details
    Drug Interactions

  • tranexamic acid

    (tranexamic acid)
    Mylan Institutional LLC
    Tranexamic acid injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.
    Medication Details
    Drug Interactions

  • tranexamic acid

    (Tranexamic Acid)
    Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Tranexamic Acid Injection is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction, typically for a duration of 2 to 8 days.
    Medication Details
    Drug Interactions